L01EM04 duvelisib
ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 1 medicine in this group.
Active substance: Duvelisib – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01EM04 duvelisib 1 medicine
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Copiktra 15 mg hard capsules | – |
Other groups of the same level
- L01EM01 idelalisib 2 medicines
- L01EM03 alpelisib 3 medicines
Other names of the ATC group
- German: L01EM04 Duvelisib
- German: L01EM04 Duvelisib
- Turkish: L01EM04 duvelisib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EM04
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.